Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Wald ratio,1,1.24 [1.15-1.32],1.22591225871549e-09,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,2,1.05 [1.03-1.08],4.75868442689704e-06,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,20,1.03 [1.01-1.04],1.00629863832396e-05,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,4,1.08 [1.04-1.12],1.0330784287065e-05,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,3,1.1 [1.05-1.16],4.62487497311223e-05,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSPOR,Wald ratio,1,1.06 [1.03-1.09],0.00013455123169052,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,2,1.05 [1.02-1.08],0.000185347165364061,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,21,1.03 [1.01-1.05],0.00206806511751177,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,8,1.09 [1.03-1.16],0.00339038391868016,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,2,1.06 [1.01-1.11],0.00914308183034681,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Wald ratio,1,1.2 [1.04-1.37],0.0126201536139681,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Wald ratio,1,1.13 [1.03-1.24],0.0126201536139682,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Wald ratio,1,1.06 [1.01-1.11],0.0150800881296611,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Wald ratio,1,1.28 [1.03-1.59],0.0234966043084663,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHFUNC,Wald ratio,1,0.79 [0.64-0.98],0.032385769578949,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,10,0.96 [0.92-1],0.0381991363485698,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,5,0.96 [0.93-1],0.0395240837405566,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,35,1.05 [1-1.09],0.0469918757095921,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,59,0.96 [0.92-1],0.048837764187795,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,4,1.12 [1-1.26],0.0553752692459208,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,1.12 [1-1.26],0.0566804417358207,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_CONSTIPATION,Wald ratio,1,0.75 [0.56-1.02],0.0698351896201412,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_INTERSTITIUM,Inverse variance weighted,4,1.04 [0.99-1.08],0.0901735400309931,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,12,1.04 [0.99-1.09],0.0984501098263329,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,2,0.87 [0.72-1.03],0.111394358831336,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,3,0.93 [0.84-1.02],0.111945251475382,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,ULCERNAS,Inverse variance weighted,18,1.02 [0.99-1.06],0.116114694958171,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_PHLETHROM,Inverse variance weighted,14,0.98 [0.95-1.01],0.132423930097931,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Wald ratio,1,1.33 [0.91-1.95],0.14562943714946,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Wald ratio,1,0.82 [0.62-1.08],0.1535220482558,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,2,0.92 [0.82-1.03],0.154233240786663,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,24,0.98 [0.95-1.01],0.163561037447582,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,2,0.88 [0.74-1.05],0.166688014466165,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Wald ratio,1,1.08 [0.97-1.2],0.166742049659354,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,JOINTPAIN,Inverse variance weighted,3,1.09 [0.97-1.23],0.167767784662512,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_PHLETHROMBDVTLOW,Inverse variance weighted,30,0.98 [0.94-1.01],0.175508568807511,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS,Inverse variance weighted,51,1.03 [0.98-1.08],0.182229956977907,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,Wald ratio,1,0.97 [0.92-1.02],0.192725557604114,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter II Neoplasms,C3_BILIARY_GALLBLADDER_EXALLC,Inverse variance weighted,3,1.04 [0.98-1.11],0.204070407296178,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Wald ratio,1,1.21 [0.9-1.61],0.207466884505404,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,COLITNONINFNAS,Wald ratio,1,1.13 [0.93-1.37],0.208443680521696,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Wald ratio,1,0.97 [0.92-1.02],0.218575425630173,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Wald ratio,1,0.89 [0.73-1.08],0.236057552775683,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,5,1.06 [0.96-1.18],0.253393049697559,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,13,0.96 [0.89-1.03],0.262133316186344,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,9,1.01 [0.99-1.04],0.265542186946451,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_VEINSOTH,Inverse variance weighted,36,0.92 [0.8-1.07],0.270149509057635,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOPATHY,Inverse variance weighted,21,1.03 [0.97-1.1],0.279528348272742,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_STR,Inverse variance weighted,3,0.87 [0.67-1.13],0.286975015579651,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_LOWERINF,Wald ratio,1,1.13 [0.9-1.41],0.291244960229592,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,0.94 [0.83-1.06],0.3020699905107,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,Inverse variance weighted,15,1 [0.99-1],0.31395106891347,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_MYCOSES,Wald ratio,1,1.08 [0.92-1.28],0.330378131299883,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,22,1.03 [0.97-1.08],0.336365452364197,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,8,1.02 [0.98-1.06],0.33773782332176,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,122,0.97 [0.91-1.03],0.348257194329274,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,4,0.92 [0.75-1.12],0.385315123716888,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_INCLAVO,Inverse variance weighted,50,1.03 [0.97-1.09],0.392000353380229,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,2,1.07 [0.91-1.26],0.400739702259816,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,G6_EPIPAROX,Inverse variance weighted,11,1.05 [0.93-1.2],0.424175175493096,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,3,0.93 [0.76-1.12],0.426579789445805,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Wald ratio,1,0.92 [0.74-1.14],0.440259999147684,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OTHERJOINT,Inverse variance weighted,16,1.04 [0.94-1.16],0.443371047178705,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,9,1.03 [0.96-1.11],0.452283028248827,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_BACTINF_NOS,Inverse variance weighted,2,0.96 [0.86-1.07],0.468940957095363,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,15,1.03 [0.95-1.13],0.470444439227371,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,24,1.02 [0.96-1.1],0.479022976395551,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHYOTH,Inverse variance weighted,27,1.03 [0.95-1.11],0.48637687328495,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,5,0.98 [0.93-1.04],0.491235236940424,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,COPD_HOSPITAL_MAIN,Inverse variance weighted,7,1.03 [0.94-1.14],0.49453454052779,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,61,0.98 [0.93-1.03],0.495176666427311,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,10,0.99 [0.94-1.03],0.50023604132832,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,14,0.99 [0.96-1.02],0.505750917565255,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_GASTRODUOULC,Inverse variance weighted,4,1.29 [0.61-2.76],0.507799899212077,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,3,0.99 [0.96-1.02],0.510451447219807,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_POLY,Wald ratio,1,0.96 [0.86-1.08],0.521643536495822,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,4,0.98 [0.91-1.05],0.526238544987819,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,13,0.98 [0.93-1.04],0.526826586650401,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,Wald ratio,1,1.11 [0.79-1.57],0.534318293091503,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Wald ratio,1,0.95 [0.8-1.12],0.54692124788867,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Wald ratio,1,0.92 [0.69-1.23],0.592447352662029,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_PAD,Inverse variance weighted,2,1.02 [0.96-1.08],0.611743195290337,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_LIMBPAIN,Wald ratio,1,1.07 [0.82-1.38],0.619232949215214,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,5,0.97 [0.86-1.09],0.636106291260201,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Wald ratio,1,0.98 [0.92-1.05],0.636489724719763,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,F5_DELIRIUM,Wald ratio,1,0.97 [0.87-1.09],0.653800817579041,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,Wald ratio,1,0.98 [0.89-1.08],0.657619290286665,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Wald ratio,1,0.96 [0.74-1.24],0.735468046196691,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,2,0.99 [0.95-1.04],0.744836797313387,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,10,1.02 [0.91-1.14],0.76040762725182,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,2,0.96 [0.71-1.31],0.805828349509221,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,7,1.01 [0.95-1.07],0.813946923760582,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,25,0.99 [0.91-1.08],0.829192318004379,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,6,1.01 [0.94-1.08],0.844787994312048,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_GALLBILPANC,Inverse variance weighted,21,1 [0.96-1.05],0.876838437191533,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,4,1 [0.93-1.06],0.88713950853738,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Wald ratio,1,1.02 [0.81-1.28],0.888027476029822,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,16,0.99 [0.89-1.11],0.89273686523638,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,5,1.01 [0.85-1.21],0.894393433698216,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,3,1 [0.95-1.05],0.900874375988325,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,4,1.01 [0.89-1.14],0.903346239841259,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOSIS,Inverse variance weighted,8,1 [0.93-1.08],0.91210702109168,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,G6_OTHNEU,Inverse variance weighted,2,0.99 [0.74-1.32],0.931710943206486,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Wald ratio,1,1 [0.93-1.09],0.937157655772006,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Wald ratio,1,1 [0.97-1.03],0.94868423093516,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SJOGREN,Inverse variance weighted,5,1 [0.95-1.05],0.962946427010362,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,3,1 [0.95-1.05],0.963664977218927,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_GULC,Wald ratio,1,1 [0.88-1.14],0.969648360644747,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_OTH,Inverse variance weighted,3,1 [0.88-1.13],0.994725207009633,trans
